AAKAAR logo

Aakaar Medical Technologies Ltd. Stock Price

NSEI:AAKAAR Community·₹1.2b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

AAKAAR Share Price Performance

₹82.25
11.00 (15.44%)
₹82.25
11.00 (15.44%)
Price ₹82.25

AAKAAR Community Narratives

There are no narratives available yet.

Recent AAKAAR News & Updates

Aakaar Medical Technologies (NSE:AAKAAR) Seems To Use Debt Quite Sensibly

Sep 30
Aakaar Medical Technologies (NSE:AAKAAR) Seems To Use Debt Quite Sensibly

Aakaar Medical Technologies Ltd. Key Details

₹615.8m

Revenue

₹262.2m

Cost of Revenue

₹353.6m

Gross Profit

₹293.2m

Other Expenses

₹60.4m

Earnings

Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
4.26
Gross Margin
57.42%
Net Profit Margin
9.81%
Debt/Equity Ratio
98.0%

Aakaar Medical Technologies Ltd. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Solid track record with slight risk.

4 Risks
2 Rewards

About AAKAAR

Founded
2013
Employees
177
CEO
Rahul Sawakhande
WebsiteView website
www.aakaarmedical.in

Aakaar Medical Technologies Ltd. provides medical aesthetics and cosmetic dermatology treatment services. Its products include hair and skin care, injectables and contouring, and aesthetic devices. The company serves primarily to dermatologists, plastic surgeons, aesthetic physicians, and cosmetologists. Additionally, it also distributes products and devices from Korea, Spain, Italy, and Austria. The company was incorporated in 2013 and is based in Mumbai, India.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

Indian Market Performance

  • 7 Days: 1.5%
  • 3 Months: -1.7%
  • 1 Year: -4.7%
  • Year to Date: 0.7%
Over the last 7 days, the market has risen 1.5%, driven by gains of 2.3% in the Financials sector. In contrast, the market has seen a decline of 4.7% over the last 12 months. Earnings are forecast to grow by 16% annually. Market details ›